Financial Performance - Revenues for Q1 2025 increased to $5,115 million, up 7.4% from $4,760 million in Q1 2024[20] - Net income for Q1 2025 was $663 million, representing a 21.4% increase compared to $546 million in Q1 2024[20] - Basic and diluted earnings per share for Q1 2025 were both $1.34, up from $1.10 in Q1 2024[20] - Comprehensive income for Q1 2025 was $794 million, compared to $484 million in Q1 2024[23] - Operating income increased by 22.7% to $853 million in Q1 2025, compared to $695 million in Q1 2024[113] - Adjusted income from operations rose by $73 million or 10.2% from Q1 2024[106] - Operating margin for Q1 2025 improved to 16.7%, up from 14.6% in Q1 2024, driven by net savings from the NextGen program and operational efficiencies[107] - Adjusted diluted EPS increased by 9.8% to $1.23 in Q1 2025, compared to $1.12 in Q1 2024[113] Revenue Breakdown - North America contributed $3,854 million to total revenues in Q1 2025, up from $3,521 million in Q1 2024, reflecting a growth of about 9.5%[36] - The Health Sciences and Financial Services segments contributed positively to revenue growth, while the Products and Resources and Communications, Media and Technology segments showed weakness[107] - Revenue for Q1 2025 increased by $355 million or 7.5% compared to Q1 2024, with an 8.2% increase in constant currency[106] - Recent acquisitions contributed 400 basis points to overall revenue growth, with a significant impact on the Products and Resources segment[117] Cash Flow and Assets - Cash generated from operating activities in Q1 2025 was $400 million, a significant increase of $305 million compared to $95 million in Q1 2024[150] - Total current assets as of March 31, 2025, were $7,545 million, slightly up from $7,504 million at the end of 2024[17] - Cash and cash equivalents at the end of Q1 2025 were $1,980 million, down from $2,231 million at the end of 2024[17] - Long-lived assets as of March 31, 2025, totaled $988 million, slightly down from $994 million as of December 31, 2024[101] Liabilities and Debt - Total liabilities decreased to $5,068 million as of March 31, 2025, down from $5,558 million at the end of 2024[17] - Long-term debt as of March 31, 2025, is $567 million, down from $875 million as of December 31, 2024, reflecting a decrease of 35.2%[52] - The company repaid $300 million of its revolving credit facility during Q1 2025, following a $600 million borrowing in Q3 2024 to fund the acquisition of Belcan[48] Tax and Legal Matters - The effective income tax rate for the three months ended March 31, 2025, is 24.4%, slightly down from 24.8% in the same period of 2024[53] - The company is involved in ongoing disputes with the Indian Tax Department regarding share repurchase transactions valued at $523 million and $2.8 billion from 2013 and 2016, respectively[53] - The ongoing legal proceedings related to Syntel resulted in a reduced damages award from $855 million to $570 million, with further evaluations pending[78] Operational Efficiency - The company reported a decrease in operational costs by H%, improving overall profitability[179] - Voluntary attrition in Tech Services was 15.8% for the trailing twelve months ended March 31, 2025, compared to 13.1% for the same period in 2024[108] Future Outlook and Investments - The company plans to continue significant investments in AI capabilities to meet client needs and enhance internal operations[110] - Market expansion efforts are underway, with plans to enter E new markets by the end of the year[179] - The company is considering strategic acquisitions to enhance its market position, with a budget of $F million earmarked for potential deals[179] Shareholder Returns - Dividends declared in Q1 2025 were $0.31 per share, totaling $154 million[26] - A dividend of $0.31 per share was declared on April 29, 2025, with a record date of May 19, 2025[103] - The company repurchased $190 million of its Class A common stock during Q1 2025, with a remaining balance of $3,047 million authorized for repurchase[173][174]

Financial Data and Key Metrics Changes - First quarter revenue grew by 8.2% year over year in constant currency to $5.1 billion, driven by the Belcan acquisition and organic growth in Health Sciences and Financial Services [6][25] - Adjusted Operating Margin improved by 40 basis points year over year to 15.5%, on track to achieve full year guidance of 20 to 40 basis points of expansion [8][33] - Adjusted EPS grew 10% year over year, marking the sixth consecutive quarter of year over year growth [8][25] Business Line Data and Key Metrics Changes - Health Sciences revenue increased over 11% year over year in constant currency, with broad-based growth across payer, provider, and life sciences [7][28] - Financial Services segment grew 6.5% year over year in constant currency, with healthy discretionary spending as clients invested in cloud and data modernization [7][28] - Products and Resources segment growth was driven by Welch, but faced weak demand due to discretionary spending pressures [29] Market Data and Key Metrics Changes - North America revenue grew 10% year over year in constant currency, driven by Belcan and large deals [30] - Europe revenue increased by 3% year over year in constant currency, supported by life sciences and financial services clients [31] - The Rest of the World saw a 7% year over year increase in constant currency, driven by large deals in Communications, Media, and Technology [32] Company Strategy and Development Direction - The company is investing heavily in AI-powered software-led engineering, integrating expertise in embedded software and IoT with capabilities from recent acquisitions [10][19] - Strategic imperatives include amplifying talent, scaling innovation, and accelerating growth, with a focus on AI and embedded engineering [16][19] - The company aims to build resilience and durability by developing leadership and talent, strengthening operational discipline, and rebooting innovation [9][10] Management's Comments on Operating Environment and Future Outlook - The macro environment changed sharply in early April, leading to elevated uncertainty, but the company sees opportunities related to productivity and efficiency [9][26] - Management remains optimistic about capturing demand in Financial Services and believes the current environment presents opportunities for cost optimization [27] - The company expects revenue growth of 5% to 6.5% year over year in constant currency for the second quarter of 2025 [35][36] Other Important Information - The company had four large deals in the first quarter, including a mega deal valued at over $500 million [8][26] - Free cash flow for the first quarter was $393 million, with plans to redeploy proceeds from the sale of an office complex in India [35] - The company plans to return approximately $1.7 billion to shareholders in 2025, including $1.1 billion in share repurchases and $600 million in dividends [39] Q&A Session Summary Question: Insights on bookings and pipeline shifts - Management noted that productivity gains from leveraging AI are leading to new deals and opportunities for consolidation, particularly in financial services [43][44] Question: Impact of April slowdown on decision-making - Management indicated that the slowdown is primarily seen in the Products and Resources segment, while Financial Services remains strong [56][57] Question: Comfort level regarding backlog coverage - Management expressed confidence in the backlog coverage, with a book-to-bill ratio of 1.3x and healthy demand in applications, AI, and cybersecurity [76] Question: Gross margin trends and expectations - Management highlighted that cost discipline will drive operating margin outcomes, with utilization and productivity improvements being key factors [78] Question: Sustainability of current growth and market position - Management emphasized the need for consistency in performance and expressed confidence in sustaining growth through a broad-based portfolio and strong market position [85][86]

Financial Data and Key Metrics Changes - First quarter revenue grew by 8.2% year over year in constant currency to $5,100 million, driven by the Belcan acquisition and organic growth in Health Sciences and Financial Services [6][25] - Adjusted Operating Margin improved by 40 basis points year over year to 15.5%, on track to achieve full year guidance of 20 to 40 basis points of expansion [8][32] - Adjusted EPS grew 10% year over year, marking the sixth consecutive quarter of year over year growth [8][25] Business Line Data and Key Metrics Changes - Health Sciences revenue increased over 11% year over year in constant currency, with broad-based growth across payer, provider, and life sciences [7][28] - Financial Services segment grew 6.5% year over year in constant currency, with healthy discretionary spending as clients invested in cloud and data modernization [7][28] - Products and Resources segment growth was driven by Welch, but overall demand environment remained weak due to discretionary spending pressures [29] Market Data and Key Metrics Changes - North America revenue grew 10% year over year in constant currency, driven by Belcan and large deals [30] - Europe revenue increased by 3% year over year in constant currency, supported by life sciences and financial services clients [30] - The Rest of the World saw a 7% year over year increase in constant currency, driven by large deals in Communications, Media, and Technology [31] Company Strategy and Development Direction - The company is investing heavily in AI-powered software-led engineering, integrating expertise in embedded software and IoT with capabilities from recent acquisitions [10][21] - Strategic imperatives include amplifying talent, scaling innovation, and accelerating growth, with a focus on AI and embedded engineering [16][19] - The company aims to build a resilient and durable organization that can thrive in both slow and high-velocity markets [5][9] Management's Comments on Operating Environment and Future Outlook - The macro environment has changed sharply, leading to elevated uncertainty, but the company sees opportunities related to productivity and efficiency [9][26] - Management remains optimistic about the pipeline for large deals and believes the current environment presents opportunities for cost optimization and vendor consolidation [26][39] - The company expects revenue growth of 3.5% to 6% in constant currency for the full year 2025, with adjusted operating margin guidance of 15.5% to 15.7% [36][37] Other Important Information - The company has approximately 1,400 early Gen AI engagements, reflecting a strong focus on AI-led productivity [11][12] - The company plans to establish a 14-acre immersive learning center in Chennai, India, to train 100,000 individuals annually in advanced AI technologies [17][20] - The company returned $364 million of capital to shareholders through share repurchases and dividends during the quarter [35] Q&A Session Summary Question: Shift in bookings and pipeline quality - Management noted that productivity gains from leveraging AI are leading to new deals and opportunities for consolidation, particularly in financial services [42][44] Question: April slowdown in decision-making - Management indicated that while there is some caution in health and products and resources sectors, financial services remain strong, and the impact is seen as isolated [56][57] Question: Organic growth and headcount changes - Management confirmed that organic growth has been driven by healthcare and financial services, with a significant improvement in utilization from 82% to 85% [64][90] Question: Confidence in cost takeout deals - Management expressed confidence that the current environment is conducive for closing cost takeout deals, despite some delays in mega deals [93]

© 2025 Cognizant Forward-looking statements This earnings supplement includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks, uncertainties and assumptions as to future events that may not prove to be accurate. These statements include, but are not limited to, express or implied forward-looking statements relating to our strategy, competitive p ...

Revenue Performance - Revenue for Q1 2025 was $5,115 million, a 7.5% increase year-over-year, and 8.2% in constant currency[3] - Revenues for Q1 2025 were $5,115 million, a 7.4% increase from $4,760 million in Q1 2024[28] - Total revenues for the three months ended March 31, 2025, were $5,115 million, representing a year-over-year increase of 7.5%[39] - Full-year 2025 revenue is expected to be between $20.5 billion and $21.0 billion, representing growth of 3.9% to 6.4%[12] - Q2 2025 revenue guidance is set between $5.14 billion and $5.21 billion, indicating growth of 5.9% to 7.4%[12] Profitability Metrics - GAAP operating margin improved to 16.7%, up 210 basis points year-over-year, while adjusted operating margin increased to 15.5%, up 40 basis points[6] - GAAP diluted EPS rose to $1.34, a 22% increase year-over-year, and adjusted diluted EPS increased to $1.23, a 10% rise[6] - Adjusted Operating Margin for Q1 2025 was 15.5%, up from 15.1% in Q1 2024[32] - Adjusted Diluted Earnings Per Share (EPS) for Q1 2025 was $1.23, compared to $1.12 in Q1 2024, representing a 9.8% increase[32] - The company anticipates full-year 2025 Adjusted Diluted EPS guidance of $4.98 to $5.14[32] Shareholder Returns - The company returned $364 million to shareholders through share repurchases and dividends, with a planned return of $1.7 billion for 2025[6] - The company repurchased 2.3 million shares under its stock repurchase program during the quarter, with a remaining authorized balance of $3,047 million[44] Bookings and Growth Indicators - Trailing 12-month bookings reached $26.7 billion, reflecting a 3% year-over-year increase, with a book-to-bill ratio of approximately 1.3x[8] - The book-to-bill ratio is a key indicator of potential future revenues, with large deals defined as those with a total contract value of $100 million or greater[25] Segment Performance - The Health Sciences segment generated $1,571 million in revenue, a 10.9% increase year-over-year, contributing 30.7% to total revenues[39] - North America accounted for $3,854 million, or 75.3% of total revenues, with a year-over-year growth of 9.5%[39] - The Products and Resources segment saw a revenue increase of 12.8% year-over-year, aided by recent acquisitions contributing approximately 400 basis points to overall revenue growth[40] Financial Position - Net income for Q1 2025 was $663 million, compared to $546 million in Q1 2024, reflecting a 21.4% year-over-year growth[28] - Total current assets as of March 31, 2025, were $7,545 million, slightly up from $7,504 million at the end of 2024[30] - Total liabilities decreased to $5,068 million as of March 31, 2025, from $5,558 million at the end of 2024[30] - Cash and cash equivalents were $1,980 million as of March 31, 2025, down from $2,231 million at the end of 2024[30] - Long-term debt decreased from $875 million at December 31, 2024, to $567 million as of March 31, 2025[37] Cash Flow - Net cash provided by operating activities was $400 million, compared to $95 million in the same period last year[42] - Free cash flow for the three months ended March 31, 2025, was $393 million, significantly up from $16 million in the prior year[46] - The company experienced a net cash used in investing activities of $7 million, compared to $238 million in the prior year[42] Strategic Initiatives - Cognizant's recent acquisitions contributed approximately 400 basis points to year-over-year revenue growth[3] - The company plans to establish a Cognizant Immersive Learning Center in Chennai, India, aimed at training 100,000 individuals annually[16] - Cognizant has entered into several strategic partnerships, including with Boehringer Ingelheim and Citizens Financial Group, to enhance technology capabilities and operational efficiencies[13]

Core Insights - Cognizant reported strong financial performance in Q1 2025, with revenue of $5.115 billion, reflecting a year-over-year increase of 7.5% and 8.2% in constant currency [3][9][40] - The company achieved a GAAP operating margin of 16.7%, up 210 basis points from the previous year, and an adjusted operating margin of 15.5%, which increased by 40 basis points year-over-year [3][9][40] - GAAP diluted EPS rose to $1.34, a 22% increase year-over-year, while adjusted diluted EPS increased by 10% to $1.23 [3][9][40] Financial Performance - Revenue growth was driven by recent acquisitions, contributing approximately 400 basis points to overall revenue growth [3][44] - The company returned $364 million to shareholders through share repurchases and dividends in Q1 2025, with a planned return of $1.7 billion for the full year [5][11] - Bookings for the trailing twelve months increased by 3% year-over-year to $26.7 billion, with a book-to-bill ratio of approximately 1.3x [6][9] Operational Highlights - The first quarter performance demonstrated strong operational rigor amid elevated uncertainty, with revenue exceeding guidance and adjusted operating margin expansion [5][9] - The company expects second quarter revenue to be between $5.14 billion and $5.21 billion, representing growth of 5.9% to 7.4% [15] - Full-year 2025 revenue guidance remains unchanged at $20.5 billion to $21.0 billion, with expected growth of 3.9% to 6.4% [15] Strategic Initiatives - Cognizant is focusing on AI-led transformation, leveraging its differentiated AI and platform capabilities to assist clients in navigating macroeconomic challenges [2][14] - Recent client agreements and partnerships include collaborations with Boehringer Ingelheim, Citizens Financial Group, and Docusign, aimed at enhancing operational efficiencies and driving innovation [16][20] - The company plans to establish a Cognizant Immersive Learning Center in Chennai, India, to train 100,000 individuals annually, reflecting its commitment to workforce development [20]

Group 1 - The upcoming report from Cognizant (CTSH) is expected to reveal quarterly earnings of $1.19 per share, indicating an increase of 6.3% compared to the year-ago period [1] - Analysts forecast revenues of $5.07 billion, representing an increase of 6.5% year over year [1] - The consensus EPS estimate for the quarter has been revised 0.5% lower over the last 30 days, reflecting a reevaluation of initial estimates by analysts [1] Group 2 - The consensus estimate for 'Revenue- Products and Resources' stands at $1.27 billion, suggesting a change of +12.2% year over year [4] - The average prediction for 'Revenue- Health Sciences' is $1.55 billion, indicating a change of +9.7% from the year-ago quarter [4] - Analysts suggest that 'Revenue- Financial services' will likely reach $1.43 billion, with a change of +3.2% from the year-ago quarter [4] Group 3 - The consensus among analysts for 'Revenue- Communications, Media and Technology' is expected to reach $835.39 million, indicating a year-over-year change of +1.1% [5] - Shares of Cognizant have demonstrated returns of -5.1% over the past month compared to the Zacks S&P 500 composite's -0.8% change [5] - Cognizant holds a Zacks Rank 3 (Hold), indicating expectations to mirror overall market performance in the near future [5]

Core Viewpoint - Cognizant Technology Solutions is expected to report first-quarter 2025 results with earnings estimated at $1.19 per share, reflecting a 6.25% increase year-over-year, and revenues projected between $5 billion and $5.1 billion, indicating a growth of 5.6%-7.1% [1][2] Revenue and Earnings Estimates - The Zacks Consensus Estimate for first-quarter revenues is $5.07 billion, representing a year-over-year increase of 6.47% [2] - Cognizant has consistently surpassed earnings estimates in the past four quarters, with an average surprise of 5.76% [2] Factors Influencing Performance - The company's performance is likely to benefit from an expanding clientele and a strong pipeline, having secured 10 large deals in Q4 2024, up from seven the previous year, totaling 29 large deals for the year [3] - Investment in artificial intelligence (AI) platforms, such as Neuro IT Ops and Flowsource, is expected to drive growth as clients increasingly adopt AI-driven automation [4] Growth Opportunities - The rising demand for GenAI solutions in sectors like financial services, healthcare, and manufacturing is anticipated to provide growth opportunities, particularly in fraud detection, medical imaging, and predictive maintenance [5] - The NextGen initiative is expected to enhance operational efficiency in the upcoming quarter [5] Clientele Expansion and Partnerships - Cognizant's extensive partner network, including companies like Omron, Docusign, and NVIDIA, is likely to contribute to growth in Q1 [6] - Recent expansion of the partnership with Docusign aims to enhance customer support and digital transformation, which is expected to positively impact performance [7] - Collaboration with OMRON focuses on integrating IT and Operational Technology in manufacturing, while a new AI-powered dispute management solution was launched in partnership with ServiceNow [8] Challenges and Market Conditions - Despite the expanding clientele, macroeconomic challenges and cost optimization pressures are expected to negatively affect top-line growth [10] - The company faces headwinds from unfavorable foreign currency exchange rates, which may reduce revenue growth and impact financial metrics [11] - A slight margin decline is anticipated in Q1 2025 due to seasonality, affecting near-term profitability [11]

Core Viewpoint - Cognizant (CTSH) is well-positioned to continue its earnings-beat streak in the upcoming report, supported by a strong history of exceeding earnings estimates, particularly in the last two quarters [1][5]. Earnings Performance - For the last reported quarter, Cognizant achieved earnings of $1.21 per share, surpassing the Zacks Consensus Estimate of $1.12 per share, resulting in a surprise of 8.04% [2]. - In the previous quarter, the company was expected to report earnings of $1.14 per share but delivered $1.25 per share, yielding a surprise of 9.65% [2]. Earnings Estimates and Predictions - Estimates for Cognizant have been trending higher, influenced by its history of earnings surprises, and the stock currently has a positive Zacks Earnings ESP (Expected Surprise Prediction), indicating a strong potential for future earnings beats [5][8]. - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise, suggesting that Cognizant may follow this trend [6]. Earnings ESP and Analyst Sentiment - Cognizant has an Earnings ESP of +0.02%, indicating that analysts are optimistic about its near-term earnings potential [8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 suggests that another earnings beat may be imminent, with the next earnings report expected on April 30, 2025 [8].

Core Insights - Cognizant has expanded its partnership with Docusign to enhance customer support and drive digital transformation [1][2] - The collaboration aims to provide innovative intelligent agreement management (IAM) solutions that optimize customer service management and streamline agreement processes globally [2][3] Partnership Details - The multi-year agreement includes comprehensive customer support services for Docusign, covering eSignature, billing inquiries, and technical support [2][5] - Cognizant's expertise in AI and digital transformation will empower Docusign to advance its IAM platform and deliver more efficient solutions to customers [3] Focus Areas - The partnership will focus on real-time customer assistance to quickly address technical issues and inquiries, aiming to improve customer satisfaction [5] - Development of comprehensive training resources to help customers effectively deploy Docusign solutions and achieve business objectives [5] - Enhanced back-office support to improve service management and maintain seamless operations for customers [5] - Onboarding consultations to assist new customers with setup, launch, and management of Docusign solutions [5]